SCHEMBL4112477

SCHEMBL4112477

O=C(O)C1CCCN(N2CCC(O)CC2)C1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.44
HSD17B10 Q99714 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
MAPT P10636 1/20 0.37
NOTUM Q6P988 1/20 0.35
TSHR P16473 2/20 0.35
SLC6A1 P30531 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
NFKB1 P19838 1/20 0.35
CYP2C19 P33261 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
LMNA P02545 1/20 0.35
AKR1C3 P42330 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2902847 0.86 ALDH1A1 (0.47) ALDH1A1HSD17B10SMN1; SMN2KDM4EMEN1
SCHEMBL20456353 0.82 NOTUM (0.42) ALDH1A1NOTUMLMNA
SCHEMBL2378473 0.76 CA12 (0.45) ALDH1A1SMN1; SMN2KDM4EKMT2ATSHR
SCHEMBL13383600 0.73 LMNA (0.47) HSD17B10KDM4EMAPTNOTUMTSHR
SCHEMBL18924943 0.72 ALDH1A1 (0.49) ALDH1A1HSD17B10SMN1; SMN2KDM4EMEN1
SCHEMBL28123975 0.72 TSHR (0.51) ALDH1A1HSD17B10SMN1; SMN2NOTUMTSHR
SCHEMBL4593908 0.71 LMNA (0.46) ALDH1A1HSD17B10KDM4EMAPTNOTUM
SCHEMBL1231703 0.71 CA12 (0.39) TSHR
SCHEMBL1862926 0.71 CA12 (0.39) TSHR
SCHEMBL6646583 0.71 CA12 (0.48) ALDH1A1SMN1; SMN2KDM4EKMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2035372-A1 MODULATORS OF THE HISTAMINE H3-RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO Arena Pharmaceuticals, Inc. (US) 2009-03-18 EP claimed
WO-2008005338-A1 MODULATORS OF THE HISTAMINE H3-RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2008-01-10 WO claimed